WebDisclosure WebDisclosure
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases Nobody Should Believe Me, LLC Remove
  1. Home
  2. Companies
  3. Nobody Should Believe Me, LLC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/16/2024 at 12:00, 1 year 10 months ago

    Dr. Sally Smith From 'Take Care of Maya' Speaks Out

    Explore the exclusive three-part interview with Dr. Sally Smith, the Florida child abuse pediatrician featured in the Netflix film 'Take Care of Maya,' on the award-winning true crime investigative podcast 'Nobody Should Believe Me.' Dr. Smith shares her side of the story, shedding light on the little-understood form of abuse known as Munchausen by proxy and discussing the controversial separation of Maya from her mother. Don't miss the explosive final installment airing on Thursday, January 18th, 2024.
    True Crime Podcast Munchausen By Proxy Dr. Sally Smith Interview Munchausen By Proxy Documentary Maya Kowalski Case
    Logo of Nobody Should Believe Me, LLC
Accesswire
  • Published on 12/05/2025 at 02:35, 4 hours 5 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 4 hours 10 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours 40 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 7 hours 35 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours 40 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 10 hours 25 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 12 hours 40 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 12 hours 55 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy